82

May 12（Saturday）
Special Lecture ST（Room 1：Sendai International Center, Conference Bldg., 2F Main Hall，9：20〜10：00）
The Dawn of a New Era in Fetal Behavioral Science

May 12 Sat.
ProgramChair：The University of Tokyo

Tomoyuki Fujii

Speaker：Kagawa University

Toshiyuki Hata︵︶

The Best of the best：Symposium 2（Reproduction/Endocrinology,
Perinatology and Womenʼs Healthcare） ST（Room 1：Sendai International Center, Conference Bldg., 2F Main Hall，13：15〜16：15）
The Latest Knowledge Obtained from the Prospective Study in the Reproduction/Perinatology and theProspect of Preemptive Medicine
Chair：Kobe University

Hideto Yamada

Showa University

Akihiko Sekizawa!

1）Efficacy of a Prospective Multifaceted Community based Intervention to Prevent Preterm Birth
Speaker：Kumamoto University

Takashi Ohba

2）Prospective Cohort Studies of Maternal and Neonatal Screening Methods for Developing Preemptive
Medicine for Congenital Infection
Speaker：Kobe University

Kenji Tanimura!

3）Elucidation of Environmental Factors and Pathological Conditions Affecting Fetal Development Focus!

on Perinatal Mental Health

Speaker：Tohoku University

Hidekazu Nishigori

4）Effects of Various Environments on the Perinatal Prognosis of Mothers and Infants
Speaker：Kyushu University

Seiichi Morokuma

Overseas Invited Lecture 12（Room 4：Sendai International Center, Conference Bldg., 2F Sakura Hall 1，16：20〜16：50）!

Evidence and Eminence in Secondary Prevention of Preterm Birth An Overview Comparing Vaginal!

Progesterone, Cerclage and Cervical Pessary in Singleton and Twin Pregnancies

Chair：Miyagi Childrenʼs Hospital / Tohoku University
Jun Murotsuki
Speaker：Philipps University/Clara Angela Foundation, Germany
Birgit Arabin

83

Overseas Invited Lecture 13（Room 5：Sendai International Center, Conference Bldg., 2F Sakura Hall 2，16：20〜16：50）
Ultrasound Grading of Cesarean Scar Pregnancies and Its Implication for the Strategy of Management：
Experience at a Single Medical Center
Chair：Tokyo Medical and Dental University

Naoyuki Miyasaka

Speaker：National Taiwan University Hospital, Taiwan
Chien-Nan Lee

May 12 Sat.
Program︵

Overseas Invited Lecture 14︶（Room 6：Sendai International Center, Conference Bldg., 3F Shirakashi Conference Room 1，16：20〜16：50）
Prevention of Preterm Birth：Progesterone vs Cerclage
Chair：Jichi Medical University

Shigeki Matsubara

Speaker：Hallym University, Korea

Keun-Young Lee

AOFOG Program（Room 12：Sendai International Center, Exhibition Bldg., Meeting Room 1，16：20〜18：20）
Opening Remarks
Speaker：The University of Tokyo/JSOG Chairperson
Tomoyuki Fujii
Gleneagles Hospital Kuala Lumpur, Malaysia/AOFOG
President

Ravi Chandran

Cervical Cancer Screening in Asian Countries
Chair：Yokohama City University/JSOG
Hirosaki University/JSOG

Etsuko Miyagi
Yoshihito Yokoyama1）Current Status and Issues of Cervical Cancer Screening in Japan
Speaker：Tohoku University/JSOG

Kiyoshi Ito2）Paradigm Change in Cervical Cancer Screening with HPV Testing
Speaker：University of Ulsan, Asan Medical Center, Korea/
AOFOG

Young-Tak Kim3）Paradigm Change in Cervical Cancer Screening with HPV Testing
Speaker：University Malaya Medical Centre, Malaysia/AOFOG
Yin-Ling Woo
4）AOFOG Initiatives for Cervical Cancer Control in Low Resource Countries
Speaker：The Royal Thai College of Obstetricians andGynaecologists, Thailand/AOFOGPisake Lumbiganon

845）Cervical Cancer in Cambodia and Its Challenges
Speaker：Cambodian Society of Gynecology and Obstetrics,
Cambodia/AOFOG

Koum Kanal

General Discussion

Closing Remarks
Speaker：The Jikei University School of Medicine/JSOG/AOFOG

May 12 Sat.
ProgramPresident-elect︵Kazunori OchiaiInternational Workshop for Junior Fellows（IWJF）︶（Room 5：Sendai International Center, Conference Bldg., 2F Sakura Hall 2，10：00〜11：50）!

1. Cross country Differences in Routine Prenatal Examinations
Chair：JSOG

Toshiyuki Takeshita

ACOG

Christopher M. Zahn

1）Cross Country Differences in Routine Prenatal Examinations：The US and Japan
Speaker：ACOG

Supraja Rajagopalan2）Routine Prenatal Examinations in Taiwan
Speaker：TAOG

Cleo Tsai!

3）The Current Status of the Guidelines of Non invasive Prenatal Testing（NIPT）in Japan, South Korea
and Taiwan
Speaker：KSOG!

Joseph J. Noh4）Cross country Differences in Routine Prenatal Examinations
Speaker：JSOG

Sayaka Kawashita

JSOG

Haruhisa Konishi

JSOG

Mamoru Shigeta!

2．Work life Balance for OB/GYN Doctors：Pregnancy and Parenthood with Careers!

Chair：JSOG

Akihiko Sekizawa

TAOG

Ming-Chao Huang1）Work life Balance for OB/GYN Doctors：Managing Pregnancy and Parenthood with Careers!

Speaker：ACOG!

Alison Dixon

2）The Challenges of Work life Balance for Female Physicians in OB GYN versus Other Specialities：
Managing Pregnancy and Parenthood with Careers
Speaker：TAOG!

Shu-Han You3）Reality of Young Korean Doctorsʼ in Marriage, Childbirth, and Child rearing：A Comprehensive
Interview Survey!

Speaker：KSOG

Se Ik Kim

4）Actual Condition of Work life Balance of OB＆GY Doctors in Japan
Speaker：JSOG

Ranka Kanda

JSOG

Naoyuki Iwahashi

JSOG

Masumi Ishibashi

85

Luncheon Seminar 25（Room 9, 10：Sendai International Center, Conference Bldg., 1F Meeting Room 1, 2，12：00〜13：00）
The Intrinsic Power of HPV Genotyping for Stratification of Cervical Cancer Risk: Efficacy and Efficiency of
the BD Onclarity Approachsponsored by Nippon Becton Dickinson Company, Ltd.
Chair：Kagoshima University

Hiroaki Kobayashi

Speaker：University of Virginia, USA

Mark H. Stoler

May 12 Sat.
Program︵Luncheon Seminar 31︶（Special Site：Sendai International Center, Exhibition Bldg., Exhibition Hall，12：00〜13：00）
Are Environmental Toxics Affecting Reproductive Health Globally―What is the Evidence?
sponsored by Canon Medical Systems Corporation
Chair：Tohoku University
Speaker：University of California, USA

Junichi Sugawara
Linda Giudice86International Session Workshop
May 12（Saturday）Room 6
Sendai International Center, Conference Bldg., 3F：Shirakashi Conference Room 1
8：00〜9：12

May 12 Sat.
ProgramGroup 1 Oncology 1 Cervical cancer/CIN
Chair：ACOG, USA Christopher M. Zahn︵︶

Dokkyo Medical University Ichio Fukasawa!

IS―WS―1― 1. Comparison of MRI, PET CT, and frozen biopsy in the evaluation of lymph node!

status before fertility sparing radical trachelectomy in early stage cervical cancer
Geon-Woo Lee（University of Ulsan College of Medicine, Asan Medical Center,
Korea）et al.

!

IS―WS―1― 2. The study about anti cancer mechanism of tetraarsenic oxide in cervical cancer
using cell line and PDX model
Jeong-Won Lee（Samsung Medical Center, Sungkyunkwan University School of
Medicine, Korea）et al.

IS―WS―1― 3. Increased myeloid derived suppressor cells during pregnancy promotes cervicalcancer progression
Katsumi Kozasa（Osaka University）et al.

IS―WS―1― 4. MicroRNAs in the cervical mucus are promising biomarkers for cervical cancer
and cervical neoplasia!

Satoshi Kawai（Fujita Health University）et al.

IS―WS―1― 5. Reduced serum miR 100 as a potential biomarker for cervical cancer
Zenta Yamanaka（Tokyo Medical University）et al.

!

IS―WS―1― 6. HPV E1 is dispensable for low and high risk HPV maintenance and latent
replication in keratinocytes but is necessary for genome amplification!

Isao Murakami（Keio University）et al.

IS―WS―1― 7. Intra patient variation of human papillomavirus genomes revealed by deep
sequencing
Yusuke Hirose（Showa University Hospital）et al.

IS―WS―1― 8. Involvement of transcription factor HOXD9 in the malignant phenotype of
cervical cancer through direct binding to HPV P97 promoter
Naohiko Saiki（Keio University）et al.

87

May 12（Saturday）Room 11
Sendai International Center, Conference Bldg., 1F：Lecture Room A, B
8：00〜9：12

Group 2 Oncology 2 Endometrial cancer/Others
Chair：Tokyo Medical University Hirotaka Nishi!

IS―WS―2― 1. Antitumor effect of XCT790, an estrogen related receptor α inverse agonist, on︵

uterine endometrial cancer cells and a xenograft mouse model
Tetsuya Kokabu（Kyoto Prefectural University of Medicine）et al.

IS―WS―2― 2. A novel epigenetic therapy with inhibition of histone methyltransferase, SETD8,
for endometrial cancer
Shinya Oki（The University of Tokyo）et al.

!

!

IS―WS―2― 3. Long term outcomes of medroxyprogesterone acetate plus metformin as fertility
sparing treatment for atypical endometrial hyperplasia and endometrial cancer

Akira Mitsuhashi（Chiba University）et al.

IS―WS―2― 4. Screening of Endometrial Cancer Using Cervical Swab!

Ling Lim（MacKay Memorial Hospital, Taiwan）et al.

IS―WS―2― 5. Genomic analysis of cell free DNA in plasma using NIPT platform by massively
parallel sequencing for a prognostic factor：gynecological tumor associated copy
number variants；a prospective study!

Makoto Nakabayashi（Showa University）et al.

IS―WS―2― 6. The malicious role of immune reaction in Uterine Serous carcinoma
Yuka Mise（Kyoto University）et al.

!

May 12 Sat.
ProgramKagoshima University Hiroaki Kobayashi!

IS―WS―2― 7. Surgical technique and outcomes of uterus retrieval from brain dead multi organ
donors：a preclinical research of human living uterine transplantation
Gaowen Chen
（Zhujiang Hospital, Southern Medical University, China）et al.

IS―WS―2― 8. Analysis of paternal contribution of genetic partial hydatidiform mole using
subtraction B allele frequency plotting of SNP array
Hirokazu Usui
（Chiba University）et al.

︶

88

May 12（Saturday）Room 12
Sendai International Center, Exhibition Bldg.：Meeting Room 1
8：20〜9：14

Group 3 Oncology 3 Ovarian cancer 1
Chair：KSOG, Korea Duk-Soo Bae

May 12 Sat.
Program︵︶

Kyorin University Yoichi Kobayashi
IS―WS―3― 1. Genomic landscape of ovarian clear cell carcinoma via next generation sequencing
Se Ik Kim
（Seoul National University College of Medicine, Korea）et al.

IS―WS―3― 2. Gene Methylation Panel of CDH1, DLEC1 and SFRP5 as Prognostic Marker in
Advanced Epithelial Ovarian Cancer
Ying-Cheng Chiang（National Taiwan University Hospital, Taiwan）et al.

IS―WS―3― 3. GSTP1 rs1695 is a predictive indicator of both hematological toxicity andprognosis of ovarian cancer treated with paclitaxel plus carboplatin
Tomoko Yoshihama（Keio University）et al.

IS―WS―3― 4. Inactivation of ZNF671 by DNA methylation is closely associated with earlyrecurrence of serous ovarian cancer
Shoko Mase（Nagoya City University）et al.

!

IS―WS―3― 5. MiR 522 modulates paclitaxel resistance in ovarian cancer cells!

Mayuko Miyamoto（Osaka University）et al.

IS―WS―3― 6. Elevated level of serum miR 1290 is correlated with high grade serous epithelial
ovarian cancer and can be a potential biomarker
Masaki Kobayashi（Osaka University）et al.

May 12（Saturday）Room 13
Sendai International Center, Exhibition Bldg.：Meeting Room 2
8：20〜9：14

Group 4 Oncology 4 Others
Chair：KSOG, Korea Hee-Sug Ryu
Kanazawa Medical University Toshiyuki Sasagawa!

IS―WS―4― 1. Cyberknife Therapy for Locally Recurrent Gynecologic Cancers After Externalbeam Radiation Therapy!

Courtney Griffiths（NYU Winthrop University Hospital, USA）et al.

IS―WS―4― 2. Withdraw!

IS―WS―4― 3. Frzb is induced by RAS MAPK signaling and contributes to transformation
Ichiro Onoyama（Kyushu University Hospital）et al.

89

IS―WS―4― 4. Lovastatin induced KLF2, KLF6 and RHOB genes and preferentially led to!

viability reduction of cisplatin resistant cells
Chiho Koi
（University of Occupational and Environmental Health）et al.

!

IS―WS―4― 5. Anticancer effect by curcumin is both associated with caspase dependent and!

caspase independent cell death in gynecological cancer cells
Tzefang Wong
（St. Marianna University School of Medicine）et al.

IS―WS―4― 6. The spliceosome U2 snRNP factors promote genome stability through distinct!

mechanisms；transcription of repair factors and R loop processing︵

May 12（Saturday）Room 14
Sendai International Center, Exhibition Bldg.：Meeting Room 3
8：00〜9：12

Group 5 Perinatology 1 Abnormal delivery/HDP
Chair：Mie University Tomoaki Ikeda
Juntendo University Atsuo Itakura
IS―WS―5― 1. Trends in maternal mortality in Mongolia in year 2016
Munkhtsetseg Davaatseren（Mongolian National University of Medical Sciences,
Mongolia）et al.

IS―WS―5― 2. Factors affecting maternal and neonatal morbidity planned for cesarean delivery
Young Mi Jung
（Seoul National University College of Medicine, Korea）et al.

IS―WS―5― 3. How do we reduce further maternal deaths in Japan?：Recommendations from theMaternal Death Exploratory Committee
Junichi Hasegawa（St. Marianna University School of Medicine）et al.

!

!!

IS―WS―5― 4. Prevention of hypothermia is important in early mother infant skin to skincontact!
!

Kentaro Kurasawa（Yokohama City University）et al.

!

!

IS―WS―5― 5. Population based trends and risk factors of early and late onset preeclampsia in
Taiwan 2001 2014
Shu-Han You（Chang Gung Memorial Hospital, Taiwan）et al.

!

IS―WS―5― 6. EEG changes and sleep/wakefulness behaviors in Pregnancy AssociatedHypertensive mice!

May 12 Sat.
ProgramMichihiro Tanikawa（The University of Tokyo）et al.

Haruna Komiya（University of Tsukuba）et al.

IS―WS―5― 7. Attenuation of angiotensin II induced preeclamptic symptoms by recombinant
thrombomodulin in mice ― a novel therapeutic approach for preeclampsia
Hiroko Oda（The University of Tokyo）et al.

IS―WS―5― 8. Possible involvemet of RAGE in Hypertensive Disorders of Pregnancy
Juria Akasaka（Nara Medical University）et al.

︶

90

May 12（Saturday）Room 15
Sendai International Center, Exhibition Bldg.：Meeting Room 4
8：00〜9：12

Group 6 Perinatology 2 Placenta/Preterm labor/Maternal complication
Chair：Kawasaki Medical School Koichiro Shimoya

May 12 Sat.
Program︵︶

University of Miyazaki Hiroshi Sameshima
IS―WS―6― 1. Endoplasmic reticulum chaperone calreticulin plays a key role in human placental
development
Naoyuki Iwahashi（Wakayama Medical University Hospital）et al.

IS―WS―6― 2. Effectiveness of Nifedipine in threatened preterm labor：a randomized trial
Chatchanawadee Na Nan（Udon Thani Hospital, Thailand）et al.

!

!

IS―WS―6― 3. Involvement of apoptosis signal regulating kinase1（ASK1）MAPK pathway in!

inflammation induced preterm birth
Midori Yoshikawa（The University of Tokyo）et al.

IS―WS―6― 4. Amniotic fluid macrophages help the healing of ruptured amnion via epithelial
mesenchymal transition（EMT）
Haruta Mogami（Kyoto University）et al.

!

IS―WS―6― 5. Anti inflammatory effect of progesterone suppresses the enhancement ofinflammatory cytokines on fetal membrane in a preterm birth mouse model withchronic dental infection
Yuko Teraoka（Hiroshima University）et al.

!

!

IS―WS―6― 6. Prevention of LPS induced preterm labor by the lack of CX3CL1 CX3CR1
interaction in mice
Mika Mizoguchi（Wakayama Medical University）et al.

!!

IS―WS―6― 7. Elimination of Mother to Child Transmission of Human Immunodeficiency!

Virus：11 Year Experience in a Single Center in Taiwan
Huang Kuan-Ying（National Taiwan University Hospital, Taiwan）et al.

!

!

IS―WS―6― 8. Comparison of One Step Versus Two Step Screening for Gestational Diabetes
Mellitus and Adverse Obstetrical Outcomes at a Single Tertiary Center in Taiwan
Cleo Tsai（Cathay General Hospital, Taipei Branch, Taiwan）et al.

91

May 12（Saturday）Room 11
Sendai International Center, Conference Bldg., 1F：Lecture Room A, B
10：35〜11：29

Group 7 Oncology 5 Ovarian cancer 2
Chair：Osaka Medical College Masahide Ohmichi

IS―WS―7― 1. Withdraw!

︵

IS―WS―7― 2. Anti cancer effect of axitinib in ovarian cancer
Myeong Seon Kim（Samsung Medical Center, Sungkyunkwan University Schoolof Medicine, Korea）et al.

!

IS―WS―7― 3. Machine Learning guided Staging in Patients with Epithelial Ovarian Cancer
E Sun Paik
（Samsung Medical Center, Sungkyunkwan University School of!

Medicine, Korea）et al.

IS―WS―7― 4. Trends and comparative analysis of patients with end stage ovarian cancer who
have received active palliative chemotherapy for the past 10 years
Jeong-Yeol Park
（Asan Medical Center, University of Ulsan College of Medicine,
Korea）et al.

!

IS―WS―7― 5. Carcinoma associated mesothelial cells orchestrate progression of peritoneal
dissemination and acquired platinum resistance in epithelial ovarian cancer
Masato Yoshihara（Nagoya University）et al.

IS―WS―7― 6. Bisphosphonates, new candidate of drug repositioning for ovarian cancer
Yusuke Kobayashi（Keio University）et al.

May 12（Saturday）Room 12
Sendai International Center, Exhibition Bldg.：Meeting Room 1
10：35〜11：29

Group 8 Oncology 6 Ovarian cancer 3
Chair：University of Tsukuba Toyomi SatohKyushu University Kiyoko Kato!

IS―WS―8― 1. The therapeutic effects of iPS cell derived myeloid cells producing interferonbeta on human ovarian cancer cells in mice!

May 12 Sat.
ProgramNihon University Kei Kawana

Yuko Imamura（Kumamoto University）et al.

IS―WS―8― 2. The role of angiopoietin like protein 2 in serous ovarian carcinoma with peritoneal
dissemination
Yuko Takeshita（Kumamoto University）et al.

︶

92

!

IS―WS―8― 3. Unmasking ovarian chemoresistant cancer cells by TSA or 5 AZA reveals new
candidates miRNAs involved in chemoresistance development
Mohamed Hassan（Faculty of Science, Port Said University, Egypt）et al.

!

IS―WS―8― 4. Tumor suppressive roles of MARK3 in high grade serous ovarian carcinomas
Hidenori Machino（The University of Tokyo）et al.

IS―WS―8― 5. Identification of somatic genetic alterations in ovarian clear cell carcinoma withnext generation sequencing
Yusuke Shibuya（Tohoku University Hospital）et al.

May 12 Sat.
Program

IS―WS―8― 6. The novel JNK inhibitor AS602801 inhibits ovarian cancer stem cells in vitro andin vivo︵

Hirotsugu Sakaki（Yamagata University Hospital）et al.

︶

May 12（Saturday）Room 13
Sendai International Center, Exhibition Bldg.：Meeting Room 2
10：35〜11：47

Group 9 Reproduction
Chair：Osaka City University Masayasu Koyama
Shiga University of Medical Science Fuminori Kimura
IS―WS―9― 1. Zfp371 is a novel DNA repair gene responsible for genome stability during mitosis
Seiji Ogawa（Keio University）et al.

IS―WS―9― 2. The function of PTENP1 in implantation
Masashi Takamura（Hudson Institute of Medical Research, Australia）

IS―WS―9― 3. C/EBPβ, but not Hif1α, regulates Vegf gene expression in granulosa cells
undergoing luteinization during ovulation after the LH surge in female rats
Masahiro Shinagawa（Yamaguchi University）et al.

IS―WS―9― 4. Activation of Endoplasmic Reticulum Stress in Granulosa Cells from Patients with
Polycystic Ovary Syndrome Contributes to Ovarian Fibrosis
Nozomi Takahashi（The University of Tokyo）et al.

IS―WS―9― 5. M2 macrophages play an essential role for successful implantation in mice
Yosuke Ono（University of Toyama）et al.

IS―WS―9― 6. Analysis of obstetric complications and outcomes related to singleton pregnancy
after embryo transfer using a large scale perinatal registry in Japan!

Yusuke Kurokawa（Kurume University Hospital）et al.

IS―WS―9― 7. Mdm2 p53 axis is a key machinery of ovulation
Hirofumi Haraguchi（The University of Tokyo Hospital）et al.

IS―WS―9― 8. A National Survey of Cryopreservation of Embryos, Oocytes, and Ovarian Tissue
for Cancer Patients
Miyuki Harada（The University of Tokyo）et al.

93

May 12（Saturday）Room 14
Sendai International Center, Exhibition Bldg.：Meeting Room 3
10：35〜11：56

Group 10 Perinatology 3 Fetal physiology/Others
Chair：National Center for Child Health and Development Haruhiko Sago

IS―WS―10― 1. Comprehensive analysis of trophoblast lineage cells from human induced︵

pluripotent stem cells（hiPSCs）
Nanae Tsuchida（Tokyo Medical University）et al.

IS―WS―10― 2. Analyses of FHR parameters and dynamics in normal fetuses according toreactivity related to fetal movement
Jeongkyu Hoh（Hanyang University of Korea, Korea）et al.

!

IS―WS―10― 3. The hemodynamic influence of twin twin transfusion syndrome on diastolic
function in recipient twins：Insight into pathophysiology
Mayumi Takano（Toho University）et al.

!

IS―WS―10― 4. Fetal baroreceptor activity in preterm fetal sheep with lipopolysaccharide
induced endotoxemia

Hyo Kyozuka（Fukushima Medical University）et al.

!

IS―WS―10― 5. Trial for a new fetal assessment by ultrasound guided photoacoustic
measurement of placental oxygen saturation
Kiguna Sei（National Defense Medical College）et al.

IS―WS―10― 6. Fetal microglia changes by maternal immune activation
Kana Ozaki（Kobe University）et al.

!

IS―WS―10― 7. Mesenchymal stem cell can induce offspringʼs immune tolerance against non!!

May 12 Sat.
Program

Ehime University Takashi Sugiyama

inherited antigens in murine Maternal to Fetal microchimeric model
Aiko Okada（Osaka University）et al.

IS―WS―10― 8. The impact of the Great East Japan Earthquake on obstetric complications：
results from the Fukushima Health Management Survey
Tsuyoshi Murata（Fukushima Medical University）et al.

IS―WS―10― 9. Efficacy of maternal screening and perinatal prevention program for hepatitis B
Tokuro Shirakawa（Kobe University）et al.

︶

94

May 12（Saturday）Room 15
Sendai International Center, Exhibition Bldg.：Meeting Room 4
10：35〜11：38

Group 11 Womenʼs health care/Others
Chair：Chiba University Makio Shozu

May 12 Sat.
Program︵︶National Defense Medical College Kenichi Furuya
IS―WS―11― 1. Amenorrhea in female athletes deteriorates bone microarchitecture of cortex
Yuriko Kitajima（Nagasaki University）et al.

IS―WS―11― 2. Bone mineral density in premenopausal women is associated with antioxidant
nutrient intake
Tamami Odai
（Tokyo Medical and Dental University）et al.

!

IS―WS―11― 3. The Evaluation of Efficiency of CRISPR/Cas9 System in Generating Fibulin 5
Knockout Mice!

Kohei Kitada（Izumiotsu Municipal Hospital）et al.

IS―WS―11― 4. A genome wide association study identifies 10 new susceptibility loci for uterine
leiomyoma in Japanese population
Kensuke Sakai（The Institute of Medical Science, The University of Tokyo）et al.

!

IS―WS―11― 5. A novel approach to treat endometriosis via targeting epithelial mesenchymaltransition
Hirotaka Masuda（Keio University）et al.

IS―WS―11― 6. Intraoperative and postoperative clinical evaluation for hysteroscopic resection of
submucosal uterine fibroids with a hysteroscopic morcellator system
Akira Tsuchiya（Teikyo University Hospital, Mizonokuchi）et al.

IS―WS―11― 7. Expression of Müllerian inhibiting substance receptor and antiproliferative effectsof MIS on human adenomyosis tissue
Youn Jee Chung（The Catholic University of Korea, Korea）et al.